Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subtypes of Melanomas Associated with Different Degrees of Actinic Elastosis in Conventional Histology, Irrespective of Age and Body Site, Suggesting Chronic Ultraviolet Light Exposure as Driver for Lentigo Maligna Melanoma and Nodular Melanoma.
Drexler K, Zenderowski V, Schreieder L, Koschitzki K, Karrer S, Berneburg M, Haferkamp S, Niebel D. Drexler K, et al. Among authors: haferkamp s. Cancers (Basel). 2023 Dec 19;16(1):1. doi: 10.3390/cancers16010001. Cancers (Basel). 2023. PMID: 38201430 Free PMC article.
IGFBP7 is not required for B-RAF-induced melanocyte senescence.
Scurr LL, Pupo GM, Becker TM, Lai K, Schrama D, Haferkamp S, Irvine M, Scolyer RA, Mann GJ, Becker JC, Kefford RF, Rizos H. Scurr LL, et al. Among authors: haferkamp s. Cell. 2010 May 14;141(4):717-27. doi: 10.1016/j.cell.2010.04.021. Cell. 2010. PMID: 20478260 Free article.
Absence of distinguishing senescence traits in human melanocytic nevi.
Tran SL, Haferkamp S, Scurr LL, Gowrishankar K, Becker TM, Desilva C, Thompson JF, Scolyer RA, Kefford RF, Rizos H. Tran SL, et al. Among authors: haferkamp s. J Invest Dermatol. 2012 Sep;132(9):2226-34. doi: 10.1038/jid.2012.126. Epub 2012 Apr 19. J Invest Dermatol. 2012. PMID: 22513787 Free article.
Oncogene-induced senescence pathways in melanocytes.
Haferkamp S, Rizos H. Haferkamp S, et al. Cell Cycle. 2010 Dec 15;9(24):4778-9. doi: 10.4161/cc.9.24.14248. Epub 2010 Dec 15. Cell Cycle. 2010. PMID: 21150332 No abstract available.
Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial.
Hart C, Vogelhuber M, Hafner C, Landthaler M, Berneburg M, Haferkamp S, Herr W, Reichle A. Hart C, et al. Among authors: haferkamp s. J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e119-e121. doi: 10.1111/jdv.13391. Epub 2015 Sep 29. J Eur Acad Dermatol Venereol. 2016. PMID: 26417987 Free PMC article. Clinical Trial. No abstract available.
155 results